Exogenous expression of tumor-derived IDH mutants suppresses histone demethylation and 5-methylcytosine hydroxylation, supporting the hypothesis that 2-HG may act as a competitive inhibitor of α-KG-dependent enzymes that control a variety of physiological activities (9). Here, IDH2 is linked to neoplasm.